Based on the knowledge and experience already gained in the research market (Novartis, Nestlé, GSK, McMaster University), Motilis improves the management of gastro-intestinal (GI) patients with its capsule based device delivering faster and better diagnosis in a more patient friendly way at reduced costs.

Motilis GI motility monitoring system is based on a magnetic tracking system (MTS) developed in collaboration with the Swiss Federal Institute of Technology (EPFL) and the University of Lausanne (UNIL, CHUV).The first product line (MTS1) was commercialized in 2007 and is used in research applications. Subsequent R&D led to the second generation product (MTS2) that will be launched on the clinical market in 2010.


Motilis Medica SA
Av. de Cour 48
CH - 1007 Lausanne

contact concerning:
+41 79 310 0908 investment
+41 79 278 1725 medical & scientific inquiry
+41 79 636 8635 manufacturing

Awards & supports